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During the past several decades our knowledge on the
effects of light on human health and its underlying
mechanisms has been expanded exponentially. These
findings have led to an enormous scientific progress
including new concepts for prevention and treatment of
many diseases such as autoimmune diseases,
cardiovascular disease, skin cancer and other malignancies.
To summarize our present knowledge on this topic and to
stimulate new research initiatives, an international
symposium entitled “Biologic Effects of Light”, that was
organized by J. Reichrath, Th. Vogt and M.F. Holick, and
that was supported by Deutsche Forschungsgemeinschaft
(DFG), was held June 11/12, 2015 in Homburg/Saar,
Germany. This meeting was specially designed to offer
scientists and clinicians a platform to discuss the latest
developments in this intriguing research area. Plenary and
Keynote lectures as well as Round Table Discussions gave
an update on carefully selected “hot topics”, including
vitamin D, skin cancer prevention, UVA radiation and
cellular homeostasis, photocarcinogenesis, and
photochemical internalization (PCI). Some of the relevant
findings and conclusions of this meeting are published in
this issue of Anticancer Research (1-13) and can be
summarized as follows:
Biologic Effects of Light for Health (M. Holick)
When human skin is exposed to sunlight or artificial broad-
spectrum lighting there exists a wide variety of photochemical
processes that occur in the skin that can influence overall
health and well-being (1). Exposure to UVB radiation is
responsible for the production of vitamin D. The association of
living at higher latitudes with increased risk for many chronic
illnesses including multiple sclerosis, type 1 diabetes,
hypertension and cardiovascular mortality has been linked to
vitamin D deficiency and the decreased efficiency of the sun
for producing vitamin D (1). People exposed to sunlight have
a feeling of well-being. This is, in part, due to the increased
expression of the proopiomelanocortin gene that produces beta
endorphin, an endogenous opioid that is much more effective
than morphine in pain relief (1). Ultraviolet A (UVA) radiation
induces the release of nitric oxide in the skin which is a known
vasodilator and may help explain why blood pressure is lower
in the summer and at lower latitudes (1). Visible radiation and
infrared radiation has been used clinically for wound healing
and improving skin health. There are a plethora of other
photochemical reactions that are occurring in the skin during
sun exposure that are only now being appreciated for their
potential health benefits (1). This overview (1) provides an
insight into many of them.
Photocarcinogenesis: Unravelling 
the Molecular Mechanisms (S. Emmert)
Cancer is a devastating disease and the second most common
cause of death in humans. To this end, skin cancer is by far
the most common type of cancer. Basal cell cancer (BCC)
followed by squamous cell cancer (SCC) may occur at a
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frequency of about 1 per 1,000 Caucasians. In Germany,
15,000 new cases of cutaneous melanoma, are diagnosed per
year and approximately every sixth patient may eventually
die from melanoma metastases (14). However, the good news
is that – depending on the type of cancer, its early detection,
and appropriate treatment – mortality from skin cancer is
low, even from melanoma. 
The reasons for cancer development are quite broad and
may include all types of processes that interfere with
genomic stability on the cellular level or immune
surveillance of de-differentiated cells on the organ level.
Concerning skin cancer risk the contribution of chronic life-
long sun exposure (non-melanoma skin cancer) or acute
sunburns (cutaneous melanoma) is well recognized. This
even led to the inclusion of UV-induced SCC in the German
ordinance on occupational diseases (15). 
On the molecular level the concept of UVB-induced dimer
formation, formation of UV fingerprint C-T mutations and
subsequently additional mutation acquisition due to knockout
of essential cell regulators like p53 as the basis of a multi-
step skin cancer development is widely accepted (16). 
However, is UVB really the main cause of skin cancer?
UVA radiation is much more abundant in the solar spectrum
compared to UVB. Indeed, it could be shown that there is a
peak in the action spectrum of skin cancer formation at 360 nm
in the UVA range (17). It has also been shown that UVA can
induce pyrimidine dimers, however, at a much lower rate
compared to UVB. In contrast with this, mutations typically
found in UVA-induced tumors are comparable to the mutation
spectrum of UVB-induced ones (C to T transitions) arising
from photodimers. This indicates that a single UVA-induced
dimer is more mutagenic than an UVB-induced dimer. To this
end, it has been shown that UVA-specific immunosuppressive
effects and reduced cell-cycle arrest lead to inhibition of the
cellular response to DNA damage (18). 
And how about the high cancer risk in organ transplant
recipients? About 40% of patients develop skin cancer or
precursors in sun-exposed areas within 5 years after
transplantation. This is reminiscent of xeroderma pigmentosum
patients who cannot properly repair photodimers due to a defect
in the nucleotide excision repair pathway. In addition, SCC
rather than BCC prevail in organ transplant recipients. And the
cancer risk depends on the immunosuppressive medication with
calcineurin inhibitors like cyclosporine A (CsA) rendering the
highest risk. Indeed, this high risk can be attributed to a reduced
immune surveillance but is exaggerated due to CsA-induced
reduction of nucleotide excision repair of photodimers. Human
papilloma viruses may act as cofactors here (19).
These two examples highlight the principles of primary skin
cancer prevention strategies: (i) photolesion reduction, and (ii)
enhancement of cellular responses to DNA damage. Lesion
reduction can be achieved by simple UV avoidance strategies
– avoid midday sun, textile sun protection, sun blockers in the
UVB and UVA range. Strategies to enhance cellular responses
to DNA damage are manifold and still developing. DNA repair
creams have been successfully applied in high-risk xeroderma
pigmentosum patients. More recently, certain antibiotics may
overcome stop codon mutations in repair genes and re-
constitute cellular repair capacity at least to some extent (20).
Other signaling pathways including vitamin D may emerge as
contributors with this respect in the future. 
Finally, the beauty of skin is its easy accessibility. This
renders secondary prevention strategies like skin cancer
screening a quick, and non-invasive task – given one knows
what he sees and draws the right conclusions. Skin
examination with the naked eye is simple, suspicious lesions
may further be evaluated with dermoscopy or – in high-risk
cancer patients with digital dermoscopy and regular follow-
up intervals. Confocal laser scan microscopy offers the
option of “non-invasive histology” in vivo. 
These and other aspects surely alleviate the fear of sun
exposure and pave the way for a safe and healthy utilization
of the beneficial aspects of solar radiation. 
UV - or Light protection: New Concepts for Skin
Cancer Prevention (L. Zastrow, J. Lademann)
Solar radiation is an evolutionary basis of human life,
inducing not only the synthesis of vitamin D but also
generating physical and mental well-being. Excessive
exposure to and high doses of solar radiation lead to complex
damages, such as immunosuppression, sunburn, photoaging
and skin cancer. The ultraviolet light (UV) is perceived by
the general public to be responsible for the almost
epidemical rise in cancer incidence. In 2006, the European
Commission recommended to approve sunscreens only if
their already existing strong protective efficacy against UVB
(280-300 nm) radiation is complemented by an adequate
protection against carcinogenic-free radicals induced in the
UVA (320–400 nm) spectral range (21).
Therefore, the efficacy of current sunscreens is excellent
in this partial range of the complete solar spectrum incident
on the earth’s surface (280-3,000 nm).
In 2009 Zastrow et al. (22) published a spectrum of
action, proving for the first time that excessive free radical
formation is the general biophysical response to solar
radiation in the range between UVB (280 nm) and near
infrared (NIR; 1,600 nm). The induced mixtures (23) of
short-lived reactive oxygen radicals (ROS) and long-lived
lipid peroxide radicals (LOS) behave exactly like the UVA-
induced free radicals, which are classified as carcinogenetic.
Surprisingly it was found that the amount of free radicals
induced by the complete solar spectrum (22) more than
doubled compared to the amount induced by the UV alone.
For the first time (24) also a free radical threshold value
(FRTV) could be detected, which functions as a “universal
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body constant”. Thereby, the numeric value of this FRTV
corresponds to the amount of ROS/LOS induced by the light
dose required for a healthy supply with vitamin D. 
Below the FRTV, i.e., in the "physiologically active"
region of the excessive radical formation, the “primary“ ROS
are dominant in the ROS/LOS mixture (23). Above the
FRTV, i.e., at light doses reaching and exceeding the minimal
erythema dose (MED), the ratio is reversed. The amount of
"secondary" LOS exceeds that of the "primary" ROS, with
the lipid peroxide-based cascade of damages extending from
biomolecular cell injury to clinically evaluable organ
damage-like sunburn. Consequently, the free radical
concentration above the FRTV is "destructive" and,
therefore, may be called "pathophysiologic".
It is well-known that people applying sunscreens stay
considerably longer in the sun. Although reduced in the UV
solar range, the radical formation in the unprotected VIS and
NIR ranges overcomes the FRTV within such short time that
the "pathophysiological" effect takes place in parallel with
the UVB-induced cascade of damage. As sun protection is
usually not provided in the VIS and NIR spectral ranges, the
radical-induced damage to the skin is much bigger than
previously supposed. In light of the globally rising skin
cancer incidence, the existing UV protective systems seem
to be almost ineffective. 
In consideration of these facts, there is an urgent need for
the development of innovative concepts starting from an
intelligent behavior in the sun, via the utilization of our
natural protective mechanisms, i.e., hyperkeratosis, tanning
and anti-oxidative potential, up to novel radiation-reducing
materials for the VIS and NIR spectral ranges. Due to the
immense impact of radiation-induced ROS/LOS on skin
carcinogenesis, anti-oxidants are of key importance in new
sunscreen formulations to ward-off these excess free radicals. 
Lademann et al. consider specific modifications of the
optical properties, i.e., reflectance and scattering, to be very
promising. Supposedly based on such modifications,
although not purposefully developed, a protective efficacy in
the VIS/IR spectral ranges could be detected in some
commercial sunscreens (24). 
New concepts for the prevention of skin carcinogenesis
indispensably require a transfer from mere UV to holistic
light protection in all spectral ranges (25). It gives hope that
some producers are already selling sunscreens claiming
“light protection”. 
Light for Treatment of Cancer and Other
Diseases: Photochemical Internalization 
(PCI), and Beyond (K. Berg)
A large number of photosensitizers are currently in use or
under clinical development for treatment of various types of
cancers based on the principle of photodynamic therapy (PDT).
PDT is under continuous development and has also recently
been further developed for enhancing the activity of other
therapeutic agents, such as macromolecular therapeutics, a
technology named photochemical internalization (PCI) (26).
These macromolecular therapeutics have been and are currently
under development to improve treatment specificity in cancer
and other diseases. The utilization of macromolecules in the
therapy of cancer and other diseases is becoming increasingly
important. Recent advances in molecular biology and
biotechnology have made it possible to improve targeting and
design of cytotoxic agents, DNA complexes and other
macromolecules for clinical applications. To achieve the
expected biological effect of these macromolecules in many
cases internalization to the cell cytosol is crucial. At an
intracellular level, the most fundamental obstruction for
cytosolic delivery of therapeutic macromolecules is the
membrane-barrier of the endocytic vesicles (27). PCI is a novel
technology for release of endocytosed macromolecules into the
cytosol. The technology is based on the use of photosensitizers
located in membranes of endocytic vesicles that upon activation
by light induce rupture of the endocytic vesicles and thereby
release of the macromolecules into the cytosol. PCI has been
shown to enhance the biological activity of a large variety of
macromolecules and other molecules that do not readily
penetrate the plasma membrane, including type I ribosome-
inactivating proteins (RIPs), gene-encoding plasmids,
adenovirus, oligonucleotides and the chemotherapeutic agent
bleomycin. For clinical utilization a novel photosensitizer has
been developed and evaluated for PCI of bleomycin. Early-
phase clinical trials have shown promising results on several
advanced cancers despite the low specificity of bleomycin. A
phase II clinical trial for the treatment of cholangiocarcinoma
has recently been initiated (NCT01900158).
Future development of PCI for delivery of targeted
macromolecules to cancers should be expected to enhance
treatment specificity, but thus far this has only been
evaluated pre-clinically. The PCI technology may be
utilized in principle on all solid cancers by delivering
light by external-beam radiation, through optical fibers to
all hollow organs, by interstitial delivery of light and
during surgical procedures. PCI is designed to primarily
be a once-off treatment with approximately one week
hospitalization. PCI could also be repeated as has been
shown in pre-clinical settings, e.g. for gene therapeutic
transfection of p53. One may envision that PCI in the
future could also be utilized for treatment of non-
cancerous diseases such as rheumatoid arthritis, but also
to treat monogene loss-of-function diseases. Current PCI
treatment requires a low cytotoxic effect induced by the
photochemical treatment to cause an efficient intracellular
translocation of macromolecular therapeutics. By
inhibiting the photochemical cytotoxicity without
perturbing the rupture of endocytic vesicles PCI could be
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used repeatedly for many diseases other than cancer. Also
very encouraging is the possible contributions to improve
development of cancer vaccines by PCI-enhanced cross-
presentations in antigen-presenting cells. Efficient
activation of CD8+ T-cells requires a strong presentation
of tumor-associated antigens by antigen-presenting cells
such as dendritic cells and macrophages. In order to
induce a sufficient antigen presentation the antigens need
to enter the cytosol in order to be processed and
transferred to the endoplasmic reticulum where the
antigen peptides can bind to MHC class I proteins and
transferred to the plasma membrane for recognition by the
immature CD8+ T-cells. The translocation of the antigens
into the cytosol from the endocytic vesicles appears to be
a bottleneck that may be substantially reduced by PCI.
Furthermore, the penetration of therapeutics through the
plasma membrane and into the cytosol is a major
limitation for the design of new therapeutics with
intracellular targets and is the main physico-chemical
restriction for the design of new chemical entities for
clinical treatments. PCI may contribute in this search for
new and specific medicines. 
Solar Simulators for Human Health: 
Challenge and Promise (G. Seckmeyer)
Humans are exposed to solar radiation which can be
described by the physical quantity radiance that is a complex
function of many parameters: Location (latitude, longitude,
height above sea level), time (diurnal, yearly variation),
wavelength, incident angle and azimuth angle. This function
varies with numerous factors. The solar exposure of humans
is, therefore, influenced by solar elevation, cloud cover,
cloud type, cloud distribution on the sky, aerosols, trace
gases in the atmosphere (e.g. ozone), obstructions by
buildings, reflections from the ground and human behavior
including variable clothing. Since the exposure is very
complex, it is a great challenge to artificially simulate natural
solar radiation. However, by doing so, it can offer unique
possibilities to study the influence of various factors in
controlled experiments on the exposure that may or may not
have a great impact on human health. 
Outlook (M.F. Holick, Th. Vogt, J. Reichrath)
Analyzing the effects of light on human health and the
underlying mechanisms has developed in recent years into a
fascinating research area. It is likely that in upcoming years
our knowledge on this topic will continue to grow and will
lead to a continuous scientific progress including new
promising concepts for the prevention and treatment of many
challenging diseases such as skin cancer and other
malignancies.
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